oxophenylarsine has been researched along with Cancer of Liver in 1 studies
oxophenylarsine: inhibits protein-tyrosine-phosphatase
phenylarsine oxide : An arsine oxide derived from phenylarsine.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, P | 1 |
| Zhang, YH | 1 |
| Zheng, XW | 1 |
| Liu, YJ | 1 |
| Zhang, H | 1 |
| Fang, L | 1 |
| Zhang, YW | 1 |
| Yang, C | 1 |
| Islam, K | 1 |
| Wang, C | 1 |
| Naranmandura, H | 1 |
1 other study available for oxophenylarsine and Cancer of Liver
| Article | Year |
|---|---|
Phenylarsine oxide (PAO) induces apoptosis in HepG2 cells via ROS-mediated mitochondria and ER-stress dependent signaling pathways.
Topics: Apoptosis; Arsenicals; Carcinoma, Hepatocellular; Endoplasmic Reticulum Stress; Humans; Liver Neopla | 2017 |